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Abstract
Background: Increases in life expectancy have resulted in a global rise in dementia prevalence. Dementia is associated
with poor wellbeing, low quality of life and increased incidence of mental health difficulties such as low mood or
depression. However, currently, there is limited access to evidence-based psychological interventions for people with
dementia experiencing low mood and poor wellbeing. Behavioural activation-based self-help, supported by informal
carers and guided by mental health professionals, may represent an effective and acceptable solution.
Methods/design: The present study is a phase II (feasibility) single-arm trial informed by the Medical Research Council
complex interventions research methods framework. Up to 50 dementia participant/informal carer dyads will be
recruited from a variety of settings including primary care, dementia-specific health settings and community outreach.
People living with dementia will receive behavioural activation-based self-help and be supported by their informal
carer who has received training in the skills required to support the self-help approach. In turn, during the use of the
intervention, the informal carer will be guided by mental health professionals to help them work through the materials
and problem solve any difficulties. Consistent with the objectives of feasibility studies, outcomes relating to recruitment
from different settings, employment of different recruitment methods, attrition, data collection procedures, clinical
delivery and acceptability of the intervention will be examined. Clinical outcomes for people with dementia (symptoms
of depression and quality of life) and informal carers (symptoms of depression and anxiety, carer burden and quality of
life) will be measured pre-treatment and at 3 months post-treatment allocation.
Discussion: This study will examine the feasibility and acceptability of a novel behavioural activation-based self-help
intervention designed to promote wellbeing and improve low mood in people living with dementia, alongside
methodological and procedural uncertainties associated with research-related procedures. As determined by
pre-specified progression criteria, if research procedures and the new intervention demonstrate feasibility and
acceptability, results will then be used to inform the design of a pilot randomised controlled trial (RCT) to specifically
examine remaining methodological uncertainties associated with recruitment into a randomised controlled design.
Trial registration: Current Controlled Trials ISRCTN42017211
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Background
Dementia is a global healthcare concern, with 115.4
million people worldwide expected to be living with
dementia by 2050 [1]. Given there are no current cure or
preventative medical interventions [2], dementia repre-
sents a significant challenge for health policy [3]. Current
estimates indicate that on a global scale, prevalence stands
at 35.6 million with 670,000 living with dementia in the
United Kingdom (UK) [4]. The provision of long-term
support to help people with dementia ‘live well’ is, there-
fore, a global health and social care priority [5–7].
Developing approaches to facilitate long-term support
is especially important given quality of life, increased
levels of mortality, increased health and social care costs
[8] and poorer functional outcomes [9] commonly experi-
enced by people with dementia [10]. Furthermore, between
30 % [11, 12] and 50 % [13] of people with dementia also
experience elevated symptoms of depression. However,
despite depression being one of the most common mental
health difficulties experienced by people living with de-
mentia [14], access to evidence-based psychological therap-
ies remains limited [15]. This treatment gap [16] exists
despite growing evidence identifying cognitive behavioural
therapy (CBT) as an effective intervention for treating
depression in people with dementia [12], partly due to
costs of delivery and a lack of trained therapists [17–19].
To provide a potential solution to address this treatment
gap, CBT provided in a self-help format is being
introduced into mental health services on a global scale
[20–23]. CBT self-help is defined as CBT-specific thera-
peutic techniques being communicated in the form of
bibliotherapy, online, audio or smartphone applications
[24, 25] as opposed to delivery by a therapist [24, 26].
Some evidence suggests effectiveness increases when
some form of face-to-face, telephone, or email guidance
or support is also provided [26–28]. Within the Improving
Access to Psychological Therapies (IAPT) Programme
implemented across England [29], support is provided by
a practitioner-based workforce (Psychological Wellbeing
Practitioners (PWPs)) and introduced alongside face-to-
face ‘high-intensity’ evidence-based psychological therapies
within a stepped care model of delivery [30]. Recent
evidence also suggests support can be provided by non-
professionals [31]. As such, a potential solution to increase
access to psychological therapies for people with dementia
may be for non-professionals, such as informal carers de-
fined as those providing unpaid and untrained support
within the community to a care recipient [32], to support
therapy delivery. The provision of informal carer itself is
associated with increased mental health difficulties such as
anxiety and depression [33], restriction of social and recre-
ational activities [34] and poor quality of life [35].
Conversely however, other evidence suggests that involving
informal carers in the facilitation of psychological
interventions for people living with dementia may also
improve caregiver mood [36].
Behavioural activation (BA) is a psychological interven-
tion featuring prominently within the IAPT programme
[37] and is an evidence-based and cost-effective [38, 39]
treatment for depression. BA aims to overcome depression
through a structured and graded approach to reintroduce
activity into people’s lives to target behavioural avoidance
[37] which is common in depression. Specifically, tech-
niques used in BA help reintroduce people to sources of
positive-reinforcement within their environment, whilst
overcoming sources of negative reinforcement that
maintain avoidance behaviours [40]. Several characteristics
of the BA self-help protocol utilised within the IAPT
programme [40] suggest it may also have potential utility
for people with dementia. Not only is BA considered a
straightforward approach making it easier for users with
dementia and their carers to understand [41] but it may
also complement the range of self-management techniques
people with dementia and carer dyads already utilise [42].
Initial evidence has already highlighted the potential utility
of BA as an effective intervention for treatment of depres-
sion in people with Alzheimer’s disease, supported by a
therapist and informal carer [36, 43]. However, these
studies focused on the use of experienced geriatricians to
deliver face-to-face therapy [36, 43], analogous to CBT
‘high-intensity’ support within a stepped care model of de-
livery [30]. Implementing this ‘high-intensity’ intervention
delivered face-to-face by an experienced geriatrician work-
force, who may already face immense demands on their
time with other aspects of their role may, therefore, be
prohibitive and unable to meet the potential demand for
treatment [44].
A research programme informed by the Medical Re-
search Council (MRC) complex interventions framework
[45] has been undertaken to develop a written BA-based
self-help intervention to target low mood and improve
wellbeing in people with dementia, supported by their
informal carers who themselves are guided in delivering
the intervention by a practitioner-based PWP workforce.
The current feasibility study builds upon MRC phase
I development work [45] previously completed. Recognising
the importance of involving people living with dementia
and their carers actively in research [46], the phase I study
involved semi-structured interviews with people with
dementia to develop a new written BA-based self-help
intervention to meet the needs of people with dementia.
Additionally, two focus groups took place with carers about
their role in supporting the person living with dementia
work through the materials and problem solve any difficul-
ties encountered under PWP guidance. This protocol
represents MRC phase II (feasibility) research [45] to exam-
ine methodological, procedural and clinical uncertainties
[47, 48]. Should progression criteria for this feasibility study
Farrand et al. Pilot and Feasibility Studies  (2016) 2:42 Page 2 of 13
be met, results will inform the design and funding applica-
tion for a further phase II (pilot) randomised controlled
trial (RCT) that will examine methodological and proced-
ural uncertainties specifically related to an RCT design.
Subsequent progression of this research programme to a
possible future definitive (phase III) RCT will be informed
by results from the piloting phase.
Study aims and objectives
A single-arm feasibility phase II study [45] with an embed-
ded qualitative component examining a number of feasi-
bility questions pertaining to methodological, procedural
and clinical uncertainties [47, 48] will be conducted.
The following outcomes will be examined following
guidance concerning feasibility study objectives, as dis-
tinguished from objectives for a pilot RCT [47]:
1. The intensity of the recruitment procedure in terms
of number of invitation packages sent by health
professionals
2. Number of health professionals required to recruit
into the study
3. The time taken (up to 6 months) to recruit the a
priori determined sample size
4. Willingness of clinicians to recruit participants
across multiple recruitment settings utilising
different recruitment strategies
5. Participant response rates between different
recruitment techniques
6. Eligibility proportions
7. Participant level barriers to recruitment.
8. Study resources required to implement study
procedures
9. Feasibility and acceptability of data collection
procedures to participants
10. Feasibility and acceptability of the intervention to
participants and clinicians
11. Barriers to clinical delivery
12. Clinician training needs
13. Clinician adherence to the intervention protocol
As determined by pre-specified progression criteria,
outcomes will be used to inform the design of a subse-
quent pilot RCT.
Methods/design
Study design
A feasibility phase II single-arm trial [45] with an embed-
ded qualitative sub-study will be conducted. This protocol
(version 1, 18/08/2015) is registered on Current Con-
trolled Trials ISRCTN42017211 and follows Standard
Protocol Items, Recommendations for Interventional Trial
(SPIRIT) [49] guidelines for reporting interventional trials.
Setting
Four different settings—general practitioners (GPs), spe-
cialist dementia healthcare settings employing Primary
Care Dementia Practitioners (PCDP), memory clinics
and community outreach in the county of Cornwall
(southwest England)—will be utilised to examine feasi-
bility outcomes associated with recruitment. All treat-
ment will be provided by PWPs within ‘step 2’ of an
IAPT primary care mental health service adopting a
stepped care model [30]. Recruitment setting locations
have been selected on the basis of locality of study PWPs
from the IAPT service to help increase the feasibility of
intervention delivery. Further, recruitment setting types
were selected on the basis of recruitment strategies
utilised in other depression [50–52] and dementia
studies [53, 54].
Eligibility criteria
People living with dementia
Participants are included if they:
1. Have a diagnosis of probable dementia recorded in
medical records, with no restriction placed on
dementia type given evidence suggesting mixed
dementia is the most common dementia
presentation [55]
2. Have mild-to-moderate dementia severity defined as
scoring between 12 and 24 on the mini-mental state
examination (MMSE) [56]
3. Have a score of 4 or more on the 12-item Geriatric
Depression Scale (GDS-12R) [57]
4. Residing at home
5. Able to provide informed consent or have an
informal carer willing to provide consultee consent
6. Have sufficient proficiency in English to read and
engage with the BA-based self-help material
7. Have an informal carer (defined as a partner, family
member or friend) who has regular contact (at least
weekly) with the person with dementia and willing
to support the intervention.
Participants receiving antidepressant medication and/
or acetyl-cholinesterase inhibitors or memantine will
also be able to participate if they have been receiving a
stable dose for at least 1 month before recruitment. No
upper or lower age restrictions are placed on people
living with dementia.
Participants are excluded if they:
1. Have a co-morbid diagnosis of a severe and
enduring mental health problem including
psychosis, type I or II bipolar disorder and
personality disorder recorded in medical records
or self-reported to the study team
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2. Are currently receiving formal psychotherapy or
another potentially active psychological treatment
3. Are acutely suicidal and/or have a history of
persistent self-injury
4. Have self-report or medical record documented
misuse of alcohol, prescription drugs or street drugs,
so severe it interferes with the person with dementia’s
ability to perform normal activities in daily life and
engagement with the intervention
Exclusions 1–3 are informed by guidance indicating that
CBT self-help is not suitable for the specific population
identified or that people with depression should only
receive one psychological intervention at a time [58].
Informal carers
Participants are included if they are:
1. Aged 16 years or over.
2. Self-identified informal carer of a person with
dementia with regular contact (at least weekly)
with the person with dementia
3. Willing to support the intervention, including
increasing contact to facilitate supporting the
intervention if required
Participants are excluded if they:
1. Score over 20 on the Patient Health Questionnaire-9
(PHQ-9) indicating severe levels of depression [59]
2. Have a co-morbid diagnosis of a severe and enduring
mental health problem including post-traumatic
stress disorder (PTSD), psychosis, type I and II
bipolar disorder or personality disorder as recorded in
medical records or self-reported to the study team
3. Have self-report or medical record documented
misuse of alcohol, prescription drugs or street drugs,
so severe it interferes with the informal carer’s ability
to perform normal activities in daily life and
engagement with the intervention
4. Have difficulties reading or following the written BA
self-help material
5. Are acutely suicidal and/or have a history of
persistent self-injury
The exclusion criteria for informal carers are based
upon clinical factors that may impair and interfere with
an informal carer’s ability to support and engage in the
intervention and indicate the carer themselves may
require psychological support.
To be included within the study, both members of the
dyad (person with dementia and informal carer) need to
meet the inclusion criteria. In the case of a person with
dementia being eligible for inclusion, but an informal
carer ineligible, the researcher will work with the dyad
to identify if another informal carer known to the dyad
may be willing to participate in the study.
Recruitment settings and procedure
A multifaceted recruitment approach will be employed,
building on techniques used to successfully recruit
carers of people with dementia [54] across four specific
recruitment settings (see Fig. 1).
GP records
GP search and mail-out will be adopted as used success-
fully in a number of depression trials [50–52]. GP elec-
tronic case records will be searched for people with a
formal diagnosis of dementia, and a manual screen will be
performed to check against the inclusion criteria. Reasons
for exclusion will be anonymised and provided to the
research team [60]. Participant invitation packages (study
invitation letter, study summary sheet, reply slip and
reasons for refusal of participation questionnaire) will be
sent to people with dementia included in the screen. This
package will also include a separate study invitation pack-
age to be passed onto an informal carer. People with
dementia, or informal carers, will be able to contact the
research team by returning the reply slip, telephoning or
emailing the research team. Given that telephone
reminders by clinicians have been reported to increase
recruitment rates [61], non-responders will be provided
with telephone follow-up calls by general practice staff.
Where phone calls receive no answer, a maximum of four
attempts to establish contact will be made over this time
period. GPs can also directly refer suitable people with de-
mentia. Study posters and brochures will also be displayed
in practice receptions to further advertise the study.
Primary care dementia practitioners
PCDPs will perform a search and mail-out. Drawn from
a variety of backgrounds in health care, PCDPs are
health professionals specialising in dementia care provid-
ing support to people living with dementia and their
families in the community. PCDPs will screen caseloads
to check against the inclusion criteria. Reasons for exclu-
sion will be anonymised and provided to the research
team. Study invitation packages will be sent in a manner
consistent with that used for GP record recruitment or
handed to potential participants face-to-face. It is antici-
pated that PCDPs will complete their initial search and
mail-out within 1 month of the study commencing
recruitment with any patients added to their caseload
over the 6-month recruitment period being invited face-
to-face. PCDPs will provide non-responders with
telephone reminders (maximum of four attempts) and
can also directly refer suitable people with dementia
during the course of the study.
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Memory service
The memory service (Consultant in Old Age Psychiatry
and Memory Assessment Nurses) will recruit potential
participants using two methods: (1) post-diagnostic
assessments with memory service staff administering
the PHQ-2, a two-item screen for possible depression
[62, 63], with people with dementia screening positive for
possible depression provided with a study invitation pack-
age and (2) a search and screening of the memory service
database for people who have received a diagnosis of de-
mentia over the preceding 24 months with those identified
as potentially eligible being sent the study invitation pack-
age in the post. In the case of post-diagnostic assessments
only, the administration of the PHQ-2 screen is included
within the recruitment procedure to help minimise the
number of people invited into the study who do not
experience low mood or depression. Post-diagnostic
assessments are conducted by health professionals experi-
enced in screening for depression (Consultant in Old Age
Psychiatry and Memory Assessment Nurses) and are the
only consistent face-to-face recruitment strategy utilised
in the study. As such, administration of the PHQ-2 screen
will only take place in this recruitment centre. Other face-
to-face recruitment techniques (e.g., GP or PCDP referral)
are designed to be more opportunistic and time limited,
as such the addition of a PHQ-2 screen was not deemed
necessary. Given that depression status may have changed
since post-diagnostic assessment, people with a diagnosis
of dementia recorded on the memory service database
will be invited to participate in the study whether or not
they have a record of depression documented. Memory
service staff will provide non-responders with telephone
Fig. 1 Flow of participants through the study
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reminders (maximum of four attempts). Anonymised
reasons for exclusion from both the post-diagnostic
assessments and database screen will be provided to the
research team.
Community outreach
A number of community-based organisations including
Memory Cafés, Memory Matters South West, the Alzhei-
mer’s Society, Carers Forum, Disability Cornwall, Dementia
Action Alliance, Age UK, Cornwall Carers and Penwith
Community Development Trust will be approached to sup-
port the study by distributing flyers and invitation packages
and displaying posters. In addition, the study will be adver-
tised by distributing study posters and leaflets in other
community locations including community day care cen-
tres; libraries, banks, bus stops, post offices, supermarkets,
cafes and community centres.
Reasons for refusal of participation
Across all recruitment settings, study invitation packages
will include refusal of participation forms for both the
person with dementia and informal carer for those who
do not wish to participate. The form includes a question-
naire listing possible reasons for refusal of participation
informed by previous research [64] as well as an open-
ended question to provide further reasons if wished. Each
package also includes a freepost envelope to enable people
with dementia and their carers to return refusal of partici-
pation forms to the study team. These data will be used to
inform barriers of recruitment and the acceptability of the
proposed intervention.
Informed consent, screening and baseline
A researcher (MA or SV) will speak to all people with
dementia and informal carers who respond to the study
invitation package or study advertisements expressing
interest to participate or seeking more information about
the study. A researcher will arrange to visit those people
with dementia and informal carers who are interested in
participating in the study, face-to-face, to obtain written
consent. Following Mental Capacity Act guidance [65],
the researchers will assess capacity to consent in people
with dementia, whilst providing appropriate support to
maximise their ability to provide consent [66]. If the person
with dementia is assessed as lacking capacity to consent,
an informal carer will be asked to act as a consultee
[65, 67]. Once consent is obtained from the informal
carer, they, alongside the person with dementia, will
undergo a face-to-face screening assessment with a re-
searcher, in a location identified by the dyad as conveni-
ent. If eligibility is confirmed for both, a full baseline
assessment will be arranged with the dyad, again in a
convenient location. After the full baseline assessment has
been conducted, dyads will be allocated to a PWP by a
member of the research team, ensuring as best as possible
an even balance across PWPs (see Fig. 1).
Sample size
A primary aim of this study is to examine the recruitment
of participants, through a variety of techniques; therefore,
the study will not stipulate a sample size a priori. Instead,
to facilitate comparisons between the effectiveness of the
recruitment approaches adopted, the study will continue
to recruit until a maximum cut-off of 50 dyads (100
participants). Fifty dyads will enable the estimation of a
follow-up rate of 80 % with a margin of error of 14 %
based on the lower bound of the 95 % confidence interval.
Intervention
Content
The BA intervention is informed by the simple BA protocol
[38, 40] originally developed for PWP delivery of low-
intensity treatment within the IAPT programme [68].
Materials
Two workbooks have been developed, one designed for
the person with dementia [69] and the other for the infor-
mal carer to aid supporting the person with dementia
work through the intervention [70]. The workbook for the
person with dementia was written in line with national
guidance for the development of dementia-friendly
written information [71] describing steps of the BA inter-
vention and providing accompanying worksheets. The
informal carer workbook provides guidance on how to
support the person with dementia implement the steps
involved within the BA protocol, alongside additional sup-
port to manage in the caring role, informed by an existing
self-help intervention for carers of stroke survivors [72].
To maximise acceptability, the content and design of both
workbooks were further informed by a series of qualitative
studies with people with dementia and their informal
carers.
Support
A PWP will guide the use of the BA self-help programme,
providing a maximum of 12 sessions over 3 months (see
Table 1 for the treatment support protocol). These 12
sessions will include one initial assessment session, one
setting up support session, up to nine brief telephone
support ‘check-ins’ representing minimal contact support
[26, 73] to the informal carer and finally, one relapse
prevention session. PWPs will follow a structured support
protocol, adapted from existing support protocols for
PWP assessment and support sessions [68] and brief
telephone support sessions [75].
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Setting
All participants will be treated within the ‘BeMe’ primary
care mental health service commissioned under the
IAPT programme [29] and part of Cornwall Partnership
NHS Foundation Trust. All face-to-face sessions will be
offered in BeMe offices, community settings or the
participants’ home if necessary to ensure inclusion into
the study for all those wishing to participate.
PWPs
PWPs will be existing employees of the IAPT primary
care mental health service supporting the study. Initially,
three existing staff members will be asked to support the
study by the service clinical lead, with additional PWPs
trained to support the study should capacity need to be
increased. All PWPs supporting the intervention will
have to successfully complete the IAPT PWP training
programme [68] to support the delivery of CBT self-help
interventions. Additionally, a 2-day training session spe-
cific to supporting the new intervention will be delivered.
Group-based clinical supervision to all PWPs supporting
the intervention will be provided once a month by the
principal investigator, PF.
PWP adherence
With participant consent, all assessment and support
sessions will be recorded. To assess adherence to the
support protocol, the marking criteria used as the basis
of competency assessments within the IAPT training
programme for PWPs will be adopted [68]. Necessary
adaptations to the support protocol and associated
marking criteria have been undertaken to ensure the
low-intensity CBT clinical method is consistent and ap-
propriate for use in the study with people with dementia
and informal carers. A sample of 20 % of sessions will be
randomly selected for each PWP, and adherence to the
support protocol will be judged by a clinician otherwise
not associated with the study. This clinician will be con-
sidered competent to mark the tapes by virtue of having
completed and passed the IAPT programme for the
training for PWPs themselves and having undertaken
additional training with the research team in the use of
the marking criteria and adaptations for a dementia
population.
Feasibility outcome measurements (primary outcome
measurements)
Data related to study feasibility will be collected to
examine the primary study objectives relating to meth-
odological, procedural and clinical uncertainties [47, 48].
Following guidance concerning feasibility study objectives
[47], Table 2 provides a summary of feasibility outcomes
to be examined, alongside progression criteria (where
applicable) to be met in order to progress to develop an
application for phase II pilot RCT funding [45].
Clinical outcome measurements (secondary outcome
measurements)
To examine the feasibility of the data collection proce-
dures, a number of clinical outcome measures will be
collected from people with dementia and their informal
carers (see Table 3).
Table 1 Treatment support protocol
Session number Attendees Method of support Session content Session duration (min)
1 Person with dementia;
informal carer; PWP
Face-to-face Problem focused assessment to identify the
main difficulties with mood and wellbeing
experienced by the person with dementia
and to introduce the BA approach. The
informal carer will also be present to act as
an informant if required.
50
2 Person with dementia;
informal carer; PWP
Face-to-face A setting up support session to help
establish the protocol for supporting the BA
self-help intervention. The rationale for the
BA intervention is discussed alongside the
procedure for the carer to provide on-going
support to the person with dementia.
40
3–11 (maximum) Informal carer; PWP Telephone Minimal contact telephone ‘check-ins’ to
check progress made with the intervention,
problem solve any difficulties experienced
with using the workbook, agree next steps
and provide on-going encouragement in
the use of the BA self-help workbooks.
Up to 15
12 Person with dementia;
informal carer; PWP
Face-to-face Relapse prevention and provision of
information to enhance on-going
signposting to appropriate health and
social care organisations as needed.
40
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Table 2 Feasibility data and method of measurement
Feasibility outcome Measurement Progression criteria to phase II pilot RCT
Recruitment Quantitative data
Percentage of people with dementia invited into the study/number of people
with dementia in total identified by health professionals
No criteria set
Number of health professionals required to assist with recruitment into the study No criteria set
The time taken (up to 6 months) to recruit up to 50 dyads No criteria set
Number of dyads enrolled into the study per week 2 dyads per week
Percentage of dyads willing to undergo screening/number invited (calculated for
GP, PCPD and memory service recruitment)
≥15 %
Percentage of dyads overall meeting the inclusion criteria/number invited ≥5 %
Percentage of dyads overall enrolled in the study/number invited ≥5 %
Qualitative data
Reasons for exclusion reported to the research team during health professional
screening (GP, PCPDs, memory service)
No criteria set
Reasons for ineligibility No criteria set
Identified barriers to recruitment (reasons for refusal of participation) No criteria set
Attrition Quantitative data
Percentage of dyads completing post-treatment (3 month) outcome measures ≥70 %
Reasons for dropout No criteria set
Qualitative data
Acceptability interviews with non-attendees and poor attendees (informal carers
and people with dementia)
No criteria set
Data collection
procedures
Quantitative data
Time taken and number of sessions to administer the screening measures ≤2 h; ≤2 sessions
Time taken and number of sessions to administer the baseline assessment ≤2 h; ≤2 sessions
Time taken and number of sessions to administer the follow-up assessments ≤2 h; ≤2 sessions
Percentage of missing items per questionnaire ≤10 %
Qualitative data
Acceptability interviews with participants concerning acceptability of research
procedures
No criteria set
Acceptability interviews with PWPs concerning acceptability and feasibility of
research procedures
No criteria set
Clinician adherence Adherence to support protocol as determined by therapy tapes ≥70 %
Clinical delivery Quantitative data
Time between being allocated to PWP and PWP undertaking the assessment
session.
≤2 weeks
Session lengths No criteria set
Number of sessions received per dyad No criteria set
Settings of sessions (e.g., BeMe, community, home) No criteria set
Number of missed appointments No criteria set
Number of missed outcome measurement items No criteria set
PWP attrition No criteria set
Impact of severity of dementia (MMSE score) informing who can engage in the
intervention
No criteria set
Qualitative data
Acceptability interviews with participants No criteria set
Acceptability interviews with PWPs No criteria set
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People with dementia
The Cornell Scale for Depression in Dementia (CSDD)
[76] will be used to assess severity of depressive symp-
toms, alongside the GDS-12R [48]. The CSDD [71] will be
used to assess severity of depressive symptoms, alongside
the GDS-12R [57, 77]. The CSDD is an interview-based
questionnaire conducted with both the person with de-
mentia and an informal carer as a proxy measure and
demonstrated to be a reliable and valid measure for people
with both mild and moderate-to-severe levels of dementia
[78, 79]. The GD-12R is reliable for people with
moderate-to-severe levels of dementia [57, 77] and recom-
mended for use in psychosocial intervention research for
people with dementia [80]. Quality of life will be
examined through the Dementia Quality of Life measure
[81] and the EuroQol-5D-3L (EQ-5D-3L) [82] validated in
a mild-to-moderate dementia population [83].
Informal carers
The PHQ-9 [84] and the Generalised Anxiety Disorder
Questionnaire (GAD-7) [85] will be administered to
assess severity of depressive and anxious symptoms,
respectively. Carer burden will be measured through the
administration of the Zarit Caregiver Burden Interview
Short Form (ZBI-12) [86]. Quality of life will be assessed
through the Medical Outcome Survey Short Form 12
(SF-12) [87] and EQ-5D-3L [82]. Health and social care
use, for both the person with dementia and informal
carer, will be collected via the administration of an
adapted version of the Client Socio-Demographic and
Service Receipt Inventory (CSRI) [88], based on two ver-
sions developed for carers of stroke survivors [74, 89]. In
addition, the CSDD-proxy [76] will be administered to
informal carers to collect further information concerning
the severity of depressive symptoms in the person with
dementia.
Sociodemographics and clinical characteristics
During the initial screen, various background, clinical
and socio-demographic characteristics—age, gender, eth-
nic background, relationship status, employment status,
highest level of academic qualification, yearly household
income, chronic physical health conditions—will be col-
lected from people with dementia and informal carers.
This will be supplemented by the additional collection of
dementia subtype diagnosed and date of diagnosis from
the person with dementia. Informal carers will also be
asked to confirm the dementia subtype diagnosed and
date of diagnosis as well as yearly household income
(if the carer does not live with the person with dementia),
length of time caring, if the carer lives with the person
with dementia, provision of care before diagnosis of
dementia, receipt of support services in the home, hours
of support services received in the home per week and
hours of caring per week.
Data collection
Researchers will collect data from the person with demen-
tia and informal carer face-to-face, at a location convenient
for the person with dementia and informal carer. To pro-
tect confidentiality, each dyad will be offered the choice of
completing outcome measurements at an alternative face-
to-face appointment to the other member of the dyad
should they prefer. Data will be collected at screening,
baseline, and post-treatment (3 months post-treatment
allocation). Clinical outcome measurements collected at
each time point are summarised in Table 3.
Intervention acceptability
Study objectives and design
An embedded qualitative study will be conducted to de-
termine the views of people with dementia and informal
carers regarding the acceptability of the BA self-help
intervention. PWPs supporting the intervention will be
interviewed with respect to the acceptability and feasibility
of the BA self-help intervention and support protocol. All
people with dementia and informal carers will be invited to
participate in semi-structured face-to-face or telephone-
based interviews using open-ended questions addressing:
1. Relevance of the intervention
2. Suitability of the intervention
Table 3 Study clinical outcome measurements by time point
Outcome measure Time point
Person with dementia
Sociodemographics Initial screen
MMSE [56] Initial screen
GDS-12R [57] Initial screen, post-treatment follow-up
CSDD [76] Baseline, post-treatment follow-up
DEMQOL [81] Baseline, post-treatment follow-up
EQ-5D-3L [82] Baseline, post-treatment follow-up
Informal carer
Sociodemographics Initial screen
PHQ-9 [84] Initial screen, post-treatment follow-up
GAD-7 [85] Baseline, post-treatment follow-up
ZBI-12 [86] Baseline, post-treatment follow-up
CSDD-proxy [76] Baseline, post-treatment follow-up
SF-12 [87] Baseline, post-treatment follow-up
EQ-5D-3L [83] Baseline, post-treatment follow-up
Revised CSRI [88] Baseline, post-treatment follow-up
MMSE mini-mental state examination, GDS-12R Geriatric Depression Scale-12
Residential, CSDD Cornell Scale for Depression in Dementia, DEMQOL Dementia
Quality of Life Measure, EQ-5D-3L EuroQol-5D-3L, PHQ-9, Health Questionnaire-9,
GAD-7 Generalised Anxiety Disorder 7-Item Scale, ZBI-12 Zarit Caregiver Burden
Interview Short Form, SF-12 12-Item Short Form Health Survey, CSRI Client Service
Receipt Inventory
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3. Impressions of guidance provided by PWPs
4. Perceived benefit of the intervention
5. Problems experienced utilising the intervention
6. Continued use of the intervention
7. Recommendations for further treatment development
8. Acceptability of research processes
The interview topic guide is informed by interview topic
guides for CBT self-help for patients with multiple scler-
osis [90] and carers of stroke survivors [74]. Informal
carers and those with dementia who have poor session
attendance will be invited to take part in an interview
session which will ask questions concerning the reasons
for disengaging with the intervention and recommenda-
tions for a more acceptable intervention. Interviews are
estimated to last between 30 and 60 min, with shorter
times expected for non/poor attendees.
Semi-structured interviews with PWPs will be conducted
over the telephone and are expected to last between 45
and 60 min. Open-ended questions will be asked about the
PWP’s impressions of the following:
1. The self-help intervention
2. Difficulties or problems encountered providing
support
3. Recommendations for future development of the
intervention and PWP training
4. Acceptability and feasibility of collecting in-session
outcome measurements
5. Acceptability and feasibility of research processes
Sampling
All participants will be invited to participate in the ac-
ceptability interviews. The research team will attempt to
interview participants categorised into one of the follow-
ing groups: (1) non-attendees (no sessions attended); (2)
poor attendees (participants who attend the assessment
session but terminate treatment prior to making a
collaborative decision with the PWP to stop treatment);
or (3) completers (engagement in treatment until a
collaborative decision with the PWP to stop treatment is
made). All study PWPs will be interviewed concerning
the acceptability of the intervention.
Statistical analysis
Quantitative
Recruitment data: where possible, data will be collected
separately from each recruitment setting to determine
recruitment rate and methodological uncertainties
associated with each specific setting. Data will be col-
lected relating to the type and number of referring sites;
number of participants identified at each site; number of
invites sent (where possible, this will not be possible
with community recruitment), number of potential
participants requesting more information, number of
consents obtained, number of screens completed, number
of baselines completed and number of participants allo-
cated to a PWP. Number of exclusions at each stage and
reasons for exclusions will also be reported. The percent-
age of eligible participants that are recruited will be
calculated with exact 95 % confidence intervals using the
cii command in Stata software version 14.0.
Feasibility of data collection procedures and accept-
ability to patients: study protocol deviations along with
reasons will be reported to assess both the feasibility and
acceptability of the data collection process. The time
taken to administer the screening measures, time taken
to administer the baseline assessment, time taken to ad-
minister the follow-up assessments and the percentage
of missing data per outcome measurement collected will
also be reported to examine the feasibility and accept-
ability of data collection procedures.
Attrition (study dropout): the number of participants
dropping out of the study will be reported, along with the
stage of dropout and reasons where possible. Attrition pro-
portions will be reported with 95 % confidence intervals.
Primary and secondary outcome measurements:
descriptive statistics including the means and standard
deviations or medians and interquartile ranges will be
reported for each outcome measurement at baseline and
3 months post-treatment allocation as these will help to
inform the sample size for the pilot RCT and later
definitive trial.
Qualitative
A thematic analysis approach [91] will be adopted to
analyse transcribed digital recordings from the inter-
views. To ensure rigour [92, 93] and confirm consistency
with generated themes, two members of the research
team (MA, SV) will analyse each interview separately
with analyses then compared. Two other research team
members (JW and PF), alongside members of the lived
experience steering committee (details below), will dis-
cuss a subset of the analysed interviews to additionally
ensure the analysis reflects the generated themes.
Lived experience steering committee
A lived experience steering committee has been estab-
lished as research collaborators [94], consisting of two
people with dementia and two informal carers (one spouse
and one adult child carer of their mother). Specifically, the
lived experience steering committee is responsible for
assisting with research activities such as developing ac-
cessible participant materials, advising on recruitment and
research procedures and supporting PWP training and
analysis of the qualitative data. The steering committee
will aim to meet monthly throughout the course of the
study as active members of the wider research team.
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Dissemination
Findings of the study will be published in an open access
journal and via conference presentation. The data from
this study will be used to inform the design and accom-
panying grant application for a future pilot RCT should
the study be considered feasible with set progression
criteria met.
Discussion
To the best of our knowledge, this feasibility study
represents the first investigation into the feasibility and
acceptability of a written BA-based self-help intervention
for the treatment of depression in people with dementia.
A BA self-help intervention, guided by PWPs and
supported by informal carers has the potential to repre-
sent an effective, acceptable and cost-effective solution
to address the significant unmet need in the provision of
psychological support for people with dementia. Further-
more, equipping informal carers with strategies to help
improve the wellbeing of care recipients may also im-
prove mood and reduce burden in the carers themselves
[36]. This current study will explore important questions
pertaining to the acceptability and feasibility of the new
intervention and research procedures.
Should the current study demonstrate feasibility and
achieve the progression criteria specified, outcomes will
be used to design and inform a funding application for a
phase II pilot RCT [45]. The aim of this pilot RCT will
be to specifically test trial processes associated with an
RCT design, with results used to develop and inform a
funding application for a future definitive phase III [45]
trial to examine effectiveness.
Study status
Study recruitment will commence in January 2016. The
final outcome data will be collected in September/
October 2016.
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